Cannabis as Medicine

Louis, Betty Wedman-St.

doi:10.1201/9780429054723

Cited by 5 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Serotonin has been implicated as a key neurotransmitter involved in the pathophysiology of anxiety, and current treatments for anxiety address its imbalance. In rodents, CBD increases serotonin release in the prefrontal cortex, an area of the brain of significance when considering anxiety in humans [52]. Allosteric modulation of 5-HT1a receptors is also a proposed mechanism of CBD's anxiolytic activity [52].…”

Section: Cannabis and Anxietymentioning

confidence: 99%

“…In rodents, CBD increases serotonin release in the prefrontal cortex, an area of the brain of significance when considering anxiety in humans [52]. Allosteric modulation of 5-HT1a receptors is also a proposed mechanism of CBD's anxiolytic activity [52]. Additionally, it has been suggested that CBD decreases the metabolism of AEA, increasing its interactions with CB1R, a potential mechanism behind the anxiolytic effects [53•].…”

Section: Cannabis and Anxietymentioning

confidence: 99%

See 1 more Smart Citation

Medicinal Cannabis for the Treatment of Anxiety Disorders: a Narrative Review

Stack

Wheate

Schubert

2022

Curr Treat Options Psych

View full text Add to dashboard Cite

Purpose of review Anxiety is a prevalent mental health condition which manifests as a disproportionate response of fear to a perceived threat. Different types of anxiety disorders vary in their pathophysiology, symptoms and treatments. The causes of anxiety disorders are complex and largely unknown; however, it has been suggested that a number of brain mechanisms and neurotransmitters are involved in the development of these conditions. While there are non-pharmacological treatments for anxiety, many patients are prescribed medications such as selective serotonin reuptake inhibitors, serotonin and noradrenaline reuptake inhibitors and/or benzodiazepines. Unfortunately, these medications have issues with efficacy and safety, and therefore, there is a continuing need for newer medicines. The cannabis constituents of tetrahydrocannabinol (THC), cannabidiol (CBD) and terpenes have been proposed as a potential treatment for anxiety conditions. Recent findings Medicinal cannabis constituents act on the endocannabinoid system (ECS) and other targets. The ECS affects several physiological functions through modulation of the central nervous system and inflammatory pathways. In particular, CBD has been suggested to exhibit anxiolytic properties, whereas THC can either have an anxiogenic or anxiolytic effect, depending on the dose, route of administration and individual genetic and environmental factors. There is also evidence that terpenes could be effective in anxiety management. Summary Currently, there is a gap in the literature as to whether standardised CBD and/or THC preparations can be used for anxiety disorders. Further information is required to know the precise doses and CBD-THC ratios from human clinical trials and real-world patient use.

show abstract

Section: Cannabis and Anxietymentioning

confidence: 99%

Section: Cannabis and Anxietymentioning

confidence: 99%